news image

March 28, 2007

By Gary A. Puckrein, PhD

For Immediate Release

March 27, 2007 | WASHINGTON, D.C.

New Web-Tool For Diabetes Touted As Great Resource For Advocacy And Policy

An innovative, online tool – the Diabetes Atlas (D-ATLAS) – was unveiled today at a briefing on Capitol Hill. The D-ATLAS is a collaborative effort among the National Minority Health Month Foundation (NMHMF); Amylin Pharmaceuticals, Inc; and Eli Lilly and Company. The D-ATLAS graphically maps type 2 diabetes prevalence by race/ethnicity, age or gender in the United States, in individual states, and in congressional and state legislative districts.

The D-ATLAS was praised by advocacy groups, and state and national elected officials as visionary and valuable. Leading health organizations and individuals engaged in providing diabetes research, education, and advocacy participated in a meeting on Capitol Hill demonstrating the utility of the D-ATLAS.

“The D-ATLAS is an important new, evidence-based tool in the effort to eliminate diabetes disparities and equip national and state stakeholders who are concerned about minority health,” said Gary Puckrein, PhD, president and CEO of the NMHMF.

Read Full Press Release Here

About The Forum

The National Minority Quality Forum (NMQF) is a 501(c)(3) not-for-profit, non-partisan, independent research and education organization. The vision of NMQF is a health services research, delivery and financing system that provides quality and effective health services to the biodiverse American general population of the 21st century. NMQF helps assure that national and local quality improvement initiatives are informed by scientific evidence, and place a priority on the quality of care and patient outcomes in all populations.